DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary


DiaMedica Therapeutics is owned by 20.07% institutional investors, 25.56% insiders, and 54.37% retail investors. Cooperman leon g is the largest institutional shareholder, holding 3.84% of DMAC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.74% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics20.07%25.56%54.37%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g1.65M3.84%$6.43M
Vanguard group1.24M2.91%$6.74M
Blackrock funding, inc. /de1.19M2.77%$4.65M
Paragon associates & paragon associates ii joint venture650.00K1.51%$2.54M
First manhattan co. llc.606.43K1.41%$2.37M
Bleichroeder lp382.32K0.89%$1.49M
Susquehanna group, llp374.85K0.88%$2.04M
Geode capital management305.75K0.72%$1.66M
Lpl financial152.00K0.36%$825.36K
Northern trust120.39K0.32%$355.15K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture650.00K4.03%$2.54M
Bleichroeder lp382.32K0.37%$1.49M
Cooperman leon g1.65M0.23%$6.43M
Catalyst financial partners38.46K0.02%$149.98K
Magnolia capital advisors10.00K0.01%$39.00K
Naples money management2.98K0.01%$8.79K
First manhattan co. llc.606.43K0.01%$2.37M
Stonebridge capital advisors17.50K0.01%$68.25K
Meridian wealth management27.32K0.00%$106.53K
Ronald blue trust69.12K0.00%$269.58K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.19M0.00%1.09M
Susquehanna group, llp374.85K0.00%273.39K
Vanguard group1.24M0.00%193.08K
Goldman sachs group68.95K0.00%68.95K
Millennium management84.83K0.00%51.14K

Top Sellers

HolderShares% AssetsChange
Aristides capital---106.33K
Jane street group---100.67K
683 capital management---76.12K
Hrt financial lp---56.70K
Qube research---36.93K

New Positions

HolderShares% AssetsChangeValue
Goldman sachs group68.95K0.00%68.95K$374.39K
Barclays27.73K-27.73K$151.00K
Jones financial companies lllp16.62K-16.62K$63.83K
Bank of montreal /can/15.56K-15.56K$84.49K
Intech investment management14.41K0.00%14.41K$56.22K

Sold Out

HolderChange
Toronto dominion bank-24.00
Jpmorgan chase-27.00
Wells fargo & company/mn-175.00
Federation des caisses desjardins du quebec-230.00
Simplex trading-374.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202557-5.00%8,620,53214.72%206.52%3911.43%5-50.00%
Mar 31, 20256027.66%7,514,09211.67%177.08%3525.00%10100.00%
Dec 31, 20244711.90%6,729,01220.58%159.24%2827.27%5-16.67%
Sep 30, 20244223.53%5,580,41110.22%137.34%2283.33%6-33.33%
Jun 30, 202434-5,063,14310.09%136.69%1250.00%912.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF747.20K1.74%-
Vanguard Total Stock Mkt Idx Inv839.16K1.63%-18.51K
iShares Russell 2000 ETF443.19K0.86%-8.40K
Vanguard Institutional Extnd Mkt Idx Tr306.18K0.59%-139.52K
Fidelity Small Cap Index263.29K0.51%263.29K
iShares Russell 2000 Growth ETF243.51K0.47%-
Fidelity Extended Market Index141.95K0.28%-370.00
Vanguard Russell 2000 ETF126.89K0.25%-7.49K
Jacob Discovery Fd Instl85.73K0.20%-4.00K
State St Russell Sm Cap® Indx SL Cl I92.50K0.18%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 22, 2025STAHLBERG JAN-Buy$356.58K
Aug 25, 2025STAHLBERG JAN-Buy$2.03M
Aug 27, 2025STAHLBERG JAN-Buy$304.63K
Aug 26, 2025STAHLBERG JAN-Buy$357.89K
Aug 21, 2025STAHLBERG JAN-Buy$287.03K

Insider Transactions Trends


DateBuySell
2025 Q33-
2025 Q2--
2025 Q1--
2024 Q22-
2024 Q1--

DMAC Ownership FAQ


Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 20.07%, followed by 25.56% insiders and 54.37% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 306.59%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (1.65M shares, 3.84%), Vanguard group (1.24M shares, 2.91%), and Blackrock funding, inc. /de (1.19M shares, 2.77%). Together, they hold 9.52% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

BlackRock is not among the top 10 institutional shareholders of DiaMedica Therapeutics.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.03% of its assets in 650K DiaMedica Therapeutics shares, valued at 2.54M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of DiaMedica Therapeutics shares, with 1.74% of its total shares outstanding invested in 747.2K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools